Supply Chain Council of European Union | Scceu.org
Distribution

Drugmakers Must Face Warranty Claims In Valsartan MDL

Law360 (January 25, 2021, 4:06 PM EST) — A New Jersey federal judge has said manufacturers, wholesalers and pharmacies cannot escape warranty claims in multidistrict litigation alleging they took part in distributing generic drugs containing the active ingredient valsartan that were tainted with carcinogens, finding that the drugs’ names and the purported contamination kept certain claims alive.

In considering dismissal bids from those defendants in three master complaints, U.S. District Judge Robert B. Kugler on Friday upheld breach of express warranty claims against manufacturers but tossed them against wholesalers and pharmacies. All three sets of defendants must face certain breach of implied warranty claims, the judge said.

The breach…

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related posts

Attorney general seeks to strengthen state’s anti-price gouging law

scceu

Through COVID-19, farmers adapt, even thrive | Special Sections

scceu

Four years after legalization, AGLC finally turns profit on cannabis

scceu